SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-22-004668
Filing Date
2022-02-28
Accepted
2022-02-28 17:15:57
Documents
1
Period of Report
2022-02-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 3519
  Complete submission text file 0001437749-22-004668.txt   4944
Mailing Address 107 SPRING STREET SEATTLE WA 98104
Business Address 107 SPRING STREET SEATTLE WA 98104 206.588.0256
ATOSSA THERAPEUTICS, INC. (Issuer) CIK: 0001488039 (see all company filings)

IRS No.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ATOSSA GENETICS INC. 1616 EASTLAKE AVE. E SUITE 510 SEATTLE WA 98102
Business Address
Guse Kyle (Reporting) CIK: 0001566618 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35610 | Film No.: 22691418